The RAPS learning platform provider will be upgrading its security posture. This will take the system off-line from 20 July through the end of the day 23 July. This will affect any Online Course, eBook, and Virtual Program Attendance. Thank you for your patience.
Regulatory Manager: What Senior Management Needs to Know About CMC Regulatory Compliance for Biotech Products Part 1: Initiating Phase 1 Clinical Trials
Posted 01 August 2009 | By
Biotechnology-derived pharmaceuticals are being developed by many companies whose senior management teams have varying degrees of familiarity or experience with the regulatory requirements for these challenging products. A 2006 independent study of the US Food and Drug Administration's (FDA) drug approval review process concluded that biotech startups and first-product biotech companies were especially at risk of failing to achieve their goal of market approval: